Jie Zheng
University of California, Los Angeles · Cellular and Integrative Physiology
Active 1987–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Jie Zheng is a Professor-in-Residence in the Department of Ophthalmology at the University of California, Los Angeles (UCLA). His research focuses on characterizing the expression profile of Dexras1 in human trabecular meshwork cells, investigating extracellular vesicles derived from corneal stromal stem cells and their effects on ANGPTL7 expression, and advancing the diagnosis and management of limbal stem cell deficiency. Zheng's work also includes studying the activation and therapeutic potential of Wnt proteins, as well as exploring metabolic profiles of trabecular meshwork cells treated with dexamethasone. His contributions extend to structural and functional insights into protein interactions relevant to cell adhesion and signaling pathways, as well as drug discovery efforts targeting Wnt signaling pathways. Zheng has authored numerous publications in the fields of biochemistry, cell biology, and vision science, emphasizing his expertise in molecular mechanisms underlying ocular health and disease.
Research topics
- Biology
- Chemistry
- Cell biology
- Medicine
- Biochemistry
Selected publications
HIF‑1α in myocardial ischemia‑reperfusion injury (Review)
Molecular Medicine Reports · 2021-03-12 · 147 citations
reviewOpen access1st authorMyocardial ischemia‑reperfusion injury (MIRI) is a severe injury to the ischemic myocardium following the recovery of blood flow. Currently, there is no effective treatment for MIRI in clinical practice. Over the past two decades, biological studies of hypoxia and hypoxia‑inducible factor‑1α (HIF‑1α) have notably improved understanding of oxygen homeostasis. HIF‑1α is an oxygen‑sensitive transcription factor that mediates adaptive metabolic responses to hypoxia and serves a pivotal role in MIRI.…
Human limbal epithelial stem cell regulation, bioengineering and function
Progress in Retinal and Eye Research · 2021-03-07 · 112 citations
reviewOpen accessPremise and peril of Wnt signaling activation through GSK-3β inhibition
iScience · 2022-03-25 · 77 citations
reviewOpen accessSenior authorCorrespondingWnt signaling pathways have been extensively studied in the context of several diseases, including cancer, coronary artery disease, and age-related disorders. β-Catenin plays a central role in the most studied Wnt pathways, the Wnt/β-catenin signaling pathway, commonly referred to as the canonical Wnt signaling pathway. β-catenin is a substrate of glycogen synthase kinase 3β (GSK-3β), and the phosphorylated β-catenin by GSK-3β can be degraded by the proteasome through ubiquitination. Thus, GSK-3…
Somatic Mutations within Myocilin due to Aging May Be a Potential Risk Factor for Glaucoma
Genes · 2024-02-04 · 2 citations
articleOpen accessSenior authorCorrespondingGlaucoma is a chronic optic neuropathy that leads to irreversible vision loss. Aging and family history are the two most important risk factors of glaucoma. One of the most studied genes involved in the onset of open-angle glaucoma is myocilin (MYOC). About 105 germline mutations within MYOC are known to be associated with glaucoma and result in endoplasmic reticulum (ER) stress, which leads to trabecular meshwork (TM) cell death and subsequent intraocular pressure (IOP) elevation. However, only…
Advances in the Diagnosis and Management of Limbal Stem Cell Deficiency
Cornea · 2024-12-19 · 2 citations
reviewOpen accessABSTRACT: This concise review focuses on the latest advancements in the diagnosis and management of limbal stem cell deficiency (LSCD). Ensuring the standard of care for individuals affected by LSCD involves the crucial task for physicians to meticulously and accurately diagnose the condition and determine its specific stage. A standardized diagnostic approach forms the foundation for formulating and delivering customized therapeutic interventions to maximize treatment outcomes for each patient.…
Recent grants
NIH · $1.3M · 2009
NIH · $1.5M · 2017
Development of small-molecule Wnt mimetics for corneal epithelial cell regeneration
NIH · $2.0M · 2018–2023
Frequent coauthors
- 36 shared
Robert Callender
Albert Einstein College of Medicine
- 35 shared
Clémence Bonnet
Centre de Recherche des Cordeliers
- 30 shared
Sophie X. Deng
University of California, Los Angeles
- 26 shared
Ju Bao
- 22 shared
John W. Burgner
- 22 shared
Jufang Shan
- 21 shared
David Cowburn
Albert Einstein College of Medicine
- 20 shared
Ho‐Jin Lee
LeMoyne–Owen College
Labs
Jie Zheng LabPI
Awards & honors
- Suzanne Eaton, Ph.D. Memorial Prize
- Taylor M. Brown Memorial Award
- Asrican Sophie & Jack Award
Similar researchers at University of California, Los Angeles
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Jie Zheng
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
